Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Stephen Waldo and Taufiq Salahuddin.

 
Connection Strength
 
 
 
2.311
 
  1. Salahuddin T, Waldo SW. Socioeconomic status, biologics and all-cause mortality in the VA healthcare system. J Eur Acad Dermatol Venereol. 2023 11; 37(11):e1326-e1327.
    View in: PubMed
    Score: 0.877
  2. Salahuddin T, Hebbe A, Kovach CP, Strobel A, Armstrong EJ, Waldo SW. Biologic therapy for psoriasis is associated with reduced risk of death: Insights from the VA clinical assessment, reporting and tracking program. J Eur Acad Dermatol Venereol. 2023 07; 37(7):e862-e864.
    View in: PubMed
    Score: 0.852
  3. Salahuddin T, Hebbe A, Daus M, Essien UR, Waldo SW, Rodriguez F, Ho PM, Simons C, Gilmartin HM, Doll JA. Trends and site-level variation of novel cardiovascular medication utilization among patients admitted for heart failure or coronary artery disease in the US Veterans Affairs System: 2017-2021. Am Heart J. 2024 02; 268:68-79.
    View in: PubMed
    Score: 0.224
  4. Salahuddin T, Richardson V, McNeal DM, Henderson K, Hess PL, Raghavan S, Saxon DR, Valle JA, Waldo SW, Ho PM, Schwartz GG. Potential unrealized mortality benefit of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transport-2 inhibitors: A report from the Veterans Health Administration Clinical Assessment, Reporting and Tracking program. Diabetes Obes Metab. 2021 01; 23(1):97-105.
    View in: PubMed
    Score: 0.180
  5. Bolden DM, Richardson V, Salahuddin T, Henderson K, Hess PL, Raghavan S, Saxon DR, Ho PM, Waldo SW, Schwartz GG. Evidence-based SGLT2 inhibitor and GLP-1 receptor agonist use by race in the VA healthcare system. Am J Prev Cardiol. 2025 Jun; 22:100966.
    View in: PubMed
    Score: 0.062
  6. Stein EJ, Mesenbring E, Smith T, Hebbe A, Salahuddin T, Waldo SW, Dyal MD, Doll JA. Intravascular Imaging as a Performance Measure for Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2025 Feb; 18(2):e014528.
    View in: PubMed
    Score: 0.061
  7. Abera SM, O'Donnell C, Salahuddin T, Prabhu K, Simons CE, Ho PM, Waldo SW, Doll JA. Assessment of Medication Adherence Using Pharmacy Data Before and After Percutaneous Coronary Intervention. Patient Prefer Adherence. 2023; 17:2789-2795.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)